Funding for this research was provided by:
National Health and Medical Research Council (APP1139561)
Received: 20 August 2019
Accepted: 10 September 2019
First Online: 18 September 2019
Ethics approval and consent to participate
: This study has received ethical approval from the Human Research Ethics Committees at the University of New South Wales (HC190136) and Tay Nguyen University (1804-QĐ-ĐHTN-TCCB). Written informed consent will be obtained from parents and guardians of all children participating in data collection, all community members receiving albendazole (or parents/guardians for those under 18 years of age), and from all participants in focus group discussions and interviews.
: Not applicable
: RMA is non-Executive Chairman of Oriole Global Health Ltd. All other authors declare that they have no competing interests.